Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mark Lobato, MD Division of TB Elimination

Similar presentations


Presentation on theme: "Mark Lobato, MD Division of TB Elimination"— Presentation transcript:

1 TB Prevention and Control in Correctional and Detention Facilities, 2006
Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention Northeast TB Controllers Meeting October 24, 2006 This is an old story, with some new recommendations for one of the residual pockets of TB in the US.

2 What’s New? (1) Bases guidelines on existing evidence
Broadens definition of corrections to include detention facilities Uses a risk assessment approach Testing by TST or QFT-Gold The recommendations now include detention centers where detainees and inmates may be held prior to trial or sentencing.

3 What’s New? (2) Highlights importance of collaboration, education, and evaluation Emphasizes case management Expands environmental controls section and adds a section on respiratory protection Recognizes the role of ICE in screening the foreign born in the U.S. Collaboration, education, and evaluation are given high visibility as important TB control activities. For the first time ICE facilities are specifically signaled out as an important venue for screening high-risk foreign born persons.

4 Symptom Screening Specifies which questions to ask
Train staff on screening interview techniques Starting with the specific questions that should be asked of inmates for symptom screening to who should ask the questions and how the interviewers should be trained.

5 TB Testing TST should be done within 7 days
Offer a menu of options (TST, QFT, CXR) HIV-infected persons require a CXR Although there was no consensus of how best to test for TB and LTBI, the participants felt that waiting 14 days before testing. A menu of options should be offered so that local and state officials who best know the populations and resources that are available could decide whether a TST or a CXR was the screening tool of choice. The role of QFT is unknown at this time, but is an acceptable option for testing.

6 Facility Risk Assessment Minimum Risk Facility
Zero TB cases in last year Not a “high-risk” population (HIV, IDU) Not large numbers of foreign born Employees not otherwise at risk for TB All other facilities are non-minimal risk The guidelines divide facilities into minimum risk and non-minimum risk based on the number of TB cases seen in the past year and the risk profile of the inmate population.

7 TB Screening: Minimal Risk Facility
Entry Screen for symptoms TB Symptoms Present? Yes Isolate and evaluate The guidelines emphasize the need for CFs to develop a risk assessment of the facility. Minimal risk facilities, i.e. no cases diagnosed, perform symptom screening. This does not mean that no testing is required. Routine testing is not called for unless the individual has a risk and that individual should be tested. No Yes TST or QFT – G CXR (HIV+) Inmate has TB risk? No No further test

8 Non-Minimum Risk Facility
Symptom review at entry immediately place symptomatic in a AII room TB test (TST, QFT-G, CXR) within 7 days CXR for HIV infected or immunosuppressed Consider therapy for positive test results

9 TB Screening: > Minimal Risk Facility
Entry Screen for symptoms TB Symptoms Present? Isolate and evaluate In non-minimum risk facilities, the screening and testing algorithm remains unchanged with the exception of adding QF as an option for testing. Renewed emphasis is placed on CXR for HIV-infected regardless of their TST result. No Obtain medical History If treatment not completed, CXR and evaluate Yes Previous TST + documented? No

10 TB Screening: > Minimal Risk Facility
No previous TST+ documented TST* or QFT-G TST+ or QFT-G? Yes CXR and evaluate No HIV+ or at risk for HIV but status unknown? Yes CXR and evaluate No *2-step testing recommended for Initial testing in facilities that perform periodic TST testing Retest periodically In long-term facilities

11 Recommendations Report suspect cases by all entities including federal facilities to local or state HD Screen all incoming inmates at entry with a symptom review Perform risk assessment Screen high risk inmates with a tuberculin skin test (or QuantiFeron-TB) within 7 days of entry Isolate TB suspects immediately Plan for discharge early Special section on ICE detainees Although some of the recommendations are not new, the prioritization and the framing of the issues are new. Reporting of TB cases to the local health entity is the responsibility of the facility including federal facilities. Screen all inmates at minimum and non-minimum risk facilities using symptoms questionnaires. Testing for TB and LTBI should be completed within 7 days of entry. Isolate immediately and plan for discharge early. And, a special section is devoted to ICE detainees.

12 New and Renewed Emphasis
Summarizes changes in treatment for TB and latent TB infection Expands collaboration between health departments and medical staff Emphasizes contact tracing and outbreak investigations Provides details for evaluation of TB control activities Offers guidance on training and education The section on treatment of TB and LTBI is a summary from the recent 2000 and 2003 guidelines. Emphasizes contact tracing and outbreak investigations Provides details on evaluation of TB control activities at the level of the facility. Discusses role of information systems Offers guidance on training and education of correctional staff as well as patients, contacts, and inmates with LTBI.

13 Jails – A Community Institution
Shelter Soup Homeless Clinic Kitchen Hospital Clinic Detention and correctional facilities are part of a larger community that needs to be taken into account. To control TB in the facility and reduce transmission in the community collaboration among these institutions is paramount. Jail Detention Center -

14 Discharge Planning Requires coordination between corrections and public health Begin soon after diagnosis Interview by health department ideally should occur before release Because most inmate-patients with TB do not complete treatment while incarcerated, case management and discharge planning becomes an important adjunct for adequate treatment.

15 Collaboration Requires formal mechanisms
Designated liaisons Regular meetings Written agreements Conduct contact investigations with input from health departments Address referral of soon-to-be released inmates TB programs are the leaders in promoting collaboration and should be actively involved in correctional contact investigations and discharge planning.

16 Evaluation Assess level of TB risk Collect and organize data
Analyze data and present conclusions Make improvements based on findings Correctional administrators, health care professionals including contracted companies and health departments should collaborate to develop a TB and infection control training program. Quality and timely data are key to evaluation.

17 Public health must go to jail.


Download ppt "Mark Lobato, MD Division of TB Elimination"

Similar presentations


Ads by Google